Hepatic hemangioendothelioma of infancy: Treatment with interferon α

Journal of Pediatric Gastroenterology and Nutrition

Volumn 24, Issue 3, 1997, Pages 348-351

  Woltering, M C ^a   Robben, S ^b   Egeler, R M ^a,b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE; RECOMBINANT ALPHA2A INTERFERON;

ABDOMINAL DISTENSION; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DRUG RESISTANCE; FEMALE; HEMANGIOENDOTHELIOMA; HEPATOMEGALY; HUMAN; HUMAN TISSUE; INFANT; LIVER BIOPSY; LIVER HEMANGIOMA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADRENAL CORTEX HORMONES; BIOPSY; DRUG RESISTANCE; FEMALE; HEMANGIOENDOTHELIOMA; HUMANS; INFANT; INTERFERON ALFA-2A; LIVER NEOPLASMS;

EID: 0030916684     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199703000-00019     Document Type: Article

References (23)

1. Dehner LP, Ishak KG. Vascular tumors of the liver in infants and children. Arch Pathol 1971;92:101-11.
2. Dachman AH, Lichtenstein JE, Friedman AC, Hartman DS. Infantile hemangioendothelioma of the liver: a radiologicpathologic-clinical correlation. Am J Roentgenol 1983;140: 1091-6.
3. Becker JM, Heitler MS. Hepatic hemangioendotheliomas in infancy. Surg Gynecol Obstet 1989;168:189-200.
4. McLean RH, Moller JH, Warick WJ, Satran L, Lucas RV. Multinodular hemangiomatosis of the liver in infancy. Pediatrics 1972;49:563-73.
5. Schild SE, Buskirk SJ, Frick LM, Cupps RE. Radiotherapy for large symptomatic hemangiomas. Int J Radiat Oncol Biol Phys 1991;21:729-35.
6. Pereyra R, Andrassy RJ, Mahour GH. Management of massive hepatic hemangiomas in infants and children: a review of 13 cases. Pediatrics 1982;70:254-8.
7. Hurvitz CH, Alkalaly AL, Sloninsky L, Kallus M, Ponerance JJ. Cyclophosphamide therapy in life-threatening vascular tumors. J Pediatr 1985;109:360-3.
8. Cornelius AS, Womer RB, Jakacki R. Multiple hemangioendotheliomas of the liver. Med Pediatr Oncol 1989;17:501-4.
9. DeLorimer AA, Simpson EB, Baum RS, Carlsson E. Hepatic artery ligation for hepatic hemangiomatosis. N Engl J Med 1967;277:333-7.
10. Burrows PE, Rosenberg HC, Chuang HS. Diffuse hepatic hemangiomas: percutaneous transcatheter embolization with detachable silicone balloons. Radiology 1985;156:85-8.
11. Orchard PJ, Smith CM, Woods WG, Day DL, Dehner LP, Shapiro R. Treatment of haemangioendotheliomas with alpha interferon [Letter]. Lancet 1989;2(8662):565-7.
12. White CW, Wolf SJ, Korones DN, Sondheimer HM, Tosi MF, Yu A. Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a. J Pediatr 1991;118: 59-66.
13. Ezekowtiz A, Mulliken J, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992;326:1456-63.
14. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, steging, and response to treatment. J Clin Oncol 1993;11:1466-77.
15. Enjolras O, Riche MC, Merland JJ, Escande JP. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 1990;85:491-8.
16. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69: 412-22.
17. Jackson C, Greene HL, O'Neill J, Kirchner S. Hepatic hemangioendothelioma: angiographic appearance and apparent prednisone responsiveness. Am J Dis Child 1977;131:74-7.
18. Selby DM, Stocker JT, Waclawiw MA, Hitchcock CL, Ishak KG. Infantile hemangioendothelioma of the liver. Hepathology 1994;20:39-45.
19. Berger TM, Berger MF, Hoffman AD, Zimmerman D, Tönz O. Imaging diagnosis and follow-up of infantile hepatic hemangioendothelioma: a case report. Eur J Pediatr 1994;153: 100-2.
20. Brouty-Boye D, Zetter BR. Inhibition of cell motility by interferon. Science 1980;208:516-8.
21. Friesel R, Komoriya A, MacKay T. Inhibition of endothelial cell proliferation by gamma interferon. J Cell Biol 1987;104: 689-99.
22. Watanabe U, Hashimoto E, Hisamitsu T, Obata H, Hayahi N. The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C. Am J Gastroenterol 1994;89:399-403.
23. Gisslinger H, Gilly B, Woloszczuk W, et al. Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha. Clin Exp Immunol 1992;90: 363-7.